GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
181 hedge funds and large institutions have $2.1B invested in GW Pharmaceuticals Plc American Depositary Shares in 2017 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 55 increasing their positions, 47 reducing their positions, and 17 closing their positions.
82% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 17
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
17% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 47
10% more capital invested
Capital invested by funds: $1.91B → $2.1B (+$198M)
6% more funds holding
Funds holding: 170 → 181 (+11)
35% less call options, than puts
Call options by funds: $50.6M | Put options by funds: $77.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$64.5M |
| 2 |
SCM
Scopia Capital Management
New York
|
+$52.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$44.5M |
| 4 |
BlackRock
New York
|
+$35.1M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$19.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.1M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$18.1M |
| 3 |
Millennium Management
New York
|
-$14M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$11.4M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8.54M |
GWPH Hedge Fund Activity: Q3 2017 in Review
181 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q3 2017, worth a combined $2.1B — up 10% from $1.91B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new GWPH positions and 17 closed out — a net gain of 14 holders — while 55 added to existing stakes and 47 trimmed.
The largest buyer was Consonance Capital Management, opening a new position worth an estimated $64.5M. The largest seller was Fidelity Investments, cutting an estimated $26.1M.
- 181 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q3 2017, up from 170 in Q2 2017.
- Funds reported $2.1B of GW Pharmaceuticals Plc American Depositary Shares stock for Q3 2017, up 10% quarter-over-quarter.
- 31 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q3 2017 and 17 closed out, a net change of +14 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q3 2017 was Consonance Capital Management, an estimated $64.5M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q3 2017 was Fidelity Investments, an estimated $26.1M sold.
Based on aggregated 13F filings for Q3 2017.